XKRX
044820
Market cap172mUSD
Oct 08, Last price
24,300.00KRW
1D
-3.76%
1Q
24.30%
Jan 2017
-35.03%
IPO
492.72%
Name
Cosmax BTI Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Cosmax BTI, Inc., established in 1992 and headquartered in Seongnam, South Korea, specializes in the development, manufacturing, and distribution of a diverse array of items. These include cosmetic products, dietary supplements, pharmaceutical goods, and specialized packaging and machinery, primarily serving customers within South Korea. The company's comprehensive product lineup features sunscreens and foundation creams; various makeup creams and bases; hair and cleansing solutions; mascaras and nail care items; a broad spectrum of color cosmetics and skin tone formulations; lipsticks and eyeshadows; liquid lip essences; body care products and sheet masks; powder compacts and makeup pencils; and fragrances. Beyond its domestic operations, Cosmax BTI, Inc. also exports its merchandise to approximately 30 countries globally.
Key people
Co-Chief Executive Officer, Director · since 2023
Gwang Se Goh
Internal Auditor
Byeong Man Lee
Co-Chief Executive Officer, Director · since 2023
Sang Wu Lee
Non-Executive Independent Director · since 2010
Headquarters & legal address
경기도 성남시 분당구 판교로 255 (삼평동)
F동 801호
Seongnam, 41 13486
KR
F동 801호
Seongnam, 41 13486
KR
Address
255, Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do
F-801
Seongnam, 41 13486
KR
F-801
Seongnam, 41 13486
KR
Other language
COSMAX BTI, INC.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||